Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - NexImmune, Inc. | d277349dex321.htm |
| EX-31.2 - EX-31.2 - NexImmune, Inc. | d277349dex312.htm |
| EX-31.1 - EX-31.1 - NexImmune, Inc. | d277349dex311.htm |
| EX-10.10 - EX-10.10 - NexImmune, Inc. | d277349dex1010.htm |
| 10-Q - 10-Q - NexImmune, Inc. | d277349d10q.htm |
Exhibit 32.2
CERTIFICATION UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of NexImmune, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge that:
The Quarterly Report for the period ended March 31, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: May 17, 2021 | By: | /s/ John Trainer | ||||
| John Trainer | ||||||
| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |